JPMorgan Got $400M Before Inovalon Sale, Del. Justices Hear
By Leslie A. Pappas · February 21, 2024, 5:39 PM EST
Inovalon didn't properly disclose that investors that bought the healthcare data company in 2021 paid $400 million in fees to its financial adviser, a JPMorgan unit, before the transaction, a reason...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login